Describe the role that professional health care organizations and societies play in (1) monitoring quality care,

Describe the role that professional health care organizations and societies play in (1) monitoring quality care,

(2) disseminating preventative health care measures, and (3) the public’s health care literacy? Select one of the three areas above and discuss established or proposed standards that assist in explaining the role of professional health care organizations and societies.

Having Trouble Meeting Your Deadline?

Get your assignment on Describe the role that professional health care organizations and societies play in (1) monitoring quality care, completed on time. avoid delay and – ORDER NOW

health care organizations

References

Institute of Medicine, Clinical Practice Guidelines, Directions for a New Program, eds. Marilyn J. Field, editor; and Kathleen N. Lohr, editor. , Washington, D.C.: National Academy Press, 1990. [PubMed]2.

”All About OSHA,” OSHA 2056 1995. (revised), Occupational Safety and Health Administration, Department of Labor, www​.osha.gov.3.

“Joint Commission Accreditation,”http://www, jcaho.org/whoweare_frm.html4.

“NCQA Accreditation,” Business and Health, 17(1):21 (January, 1999).5.

“About URAC,”. http://www, urac.org6.

General Accounting Office. Private Health Insurance: Continued Erosion of Coverage Linked to Cost Pressures. GAO/HEHS 97–122. Washington, DC: July 1997b.7.

Hibbard, Judith H.; Jewett, Jacquelyn J.; Legnini, Mark W., et al. Choosing a Health Plan: Do Large Employers Use the Data. Health Affairs. 16(6):172–180,1997. [PubMed]8.

Washington Business Group on Health and Watson Wyatt Worldwide. Getting What You Pay for—Purchasing Value in Health Care. Bethesda, MD: Watson Wyatt Worldwide, 1997.9.

KPMG Peat Marwick. Health Benefits in 1997. Montvale, NJ: 1997.10.

http://www​.hcfa.gov.11.

“Quality of Care Information, HCFA Contractors, Peer Review Organizations,” http://www​.hcfa.gov/qlty-56.htm , last updated July 26, 1999.12.

Timothy Cuerdon, Office of Clinical Standards and Quality, Health Care Financing Administration, Testimony to the IOM Subcommittee on Creating an External Environment for Quality, June 15, 1999.13.

“Medicare and Medicaid Survey and Certification,”. http://www​.hcfa.gov/medicaid/scindex.htm [PubMed]14.

O’Neil, Edward H., and the Pew Health Professions Commission, San Francisco, CA: Pew Health Professions Commission, December 1998.15.

Finocchio, Leonard J.; Dower, Catherine M.; Blick, Noelle T., et al., Strengthen ing Consumer Protection: Priorities for Health Care Workforce Regulation, San Francisco, CA; Pew Health Professions Commission, October 1998.16.

Maintaining State-Based Licensure and Discipline: A Blueprint for Uniform and Effective Regulation of the Medical Profession, Federation of State Medical Boards of the United States, Inc., 1998. http://www​.fsmb.org.17.

Sidney M. Wolfe, “Public Citizen’s Health Research Group Ranking of State Medical Boards’ Serious Disciplinary Actions in 1998,” April, 1999, http://www​.citizen.org . Serious disciplinary actions include revocations, surrenders, suspensions and probations/restrictions on licensure.18.

Timberg, Craig, “Virginia’s Physician Discipline Board too Slow to Act, Audit Finds,” Washington Post, June 15, 1999, p. A20.19.

Finocchio, Dower, Blick, et al., 1998.20.

Finocchio, Dower, Blick, et al., 1998.21.

“What Is ABMS?” http://www​.abms.org/purpose.html.22.

Prager, Linda O. Upping the Certification Ante. American Medical News. 42(21): 1,1999. Also, American Board of Internal Medicine, Continuing Professional Development. September, 1999. See also: Norcini, John J., “Computer-Based Testing Will Soon Be a Reality,” Perspective, American Board of Internal Medicine, Summer, 1999, p. 3.23.

“A Definition,” http://www​.ama-assn.org​/med-sci/amapsite/about/define.htm.24.

Finocchio, Dower, Blick, et al., 1998.25.

Computerized Clinical Simulation Testing (CST), National Council of State Boards of Nursing, Inc., 1999. http://www​.ncsbn.org.26.

Pierce, Ellison C. The 34th Rovenstine Lecture, 40 Years Behind the Mask: Safety Revisited. Anesthesiology. 87(4):965–975,1996. [PubMed]27.

http://www​.acc.org/clinical/guidelines.28.

President’s Commission on Consumer Protection and Quality in Health Care. Quality First: Better Health Care for Ali Americans. Final Report to the President of the United States, March 1997.29.

Food and Drug Administration, “Managing the Risks From Medical Product Use, Creating a Risk Management Framework,” Executive Summary, Report to the FDA Commissioner from the Task Force on Risk Management, May 1999.30.

Additional strategies include field investigations, epidemiological studies and other focused studies.31.

Food and Drug Administration, “Managing the Risks From Medical Product Use, Creating a Risk Management Framework,” Report to the FDA Commissioner from the Task Force on Risk Management, U.S. Department of Health and Human Services, May 1999.32.

Food and Drug Administration, “Improving Public Health Through Human Drugs,” CDER 1998 Report to the Nation, Center for Drug Evaluation and Research, health care organizations USDHHS.33.

Shatin, Deborah; Gardner, Jacqueline; Stergachis, Andy; letter. JAMA 281(4): 319–320,1999. [PubMed]34.

Friedman, Michael A.; Woodcock, Janet; Lumpkin, Murray M., et al. The Safety of Newly Approved Medicines, Do Recent Market Removals Mean There Is a Problem? JAMA health care organizations281(18):1728–1934,1999. [PubMed]35.

Food and Drug Administration. Managing the Risks From Medical Product Use, Creating a Risk Management Framework. Report to the FDA Commissioner from the Task Force on Risk Management, U.S. Department of Health and Human Services, health care organizationsMay 1999.36.

Friedman, Woodcock, Lumpkin, et al, 1999. Also Wood, Alastair J.J. The Safety of New Medicines. JAMA health care organizations281(18):1753–1754,1999. [PubMed]37.

Moore, Thomas J; Psaty, Bruce M; Furberg, Curt D. Time to Act on Drug Safety. JAMA, 279(19):1571–1573,1998. [PubMed]38.

Moore, Psaty, and Furberg, 1998. See also Wood, Alastair J.J. and Woosely, Raymond. Making Medicine Safer, The Need for an Independent Drug Safety Review Board. health care organizationsN Engl J Med. 339(25):1851–1853,1998. [PubMed]39.

Weinger, Matthew; Pantiskas, Carl; Wiklund, Michael, et al. Incorporating Human Factors Into the Design of Medical Devices health care organizations. JAMA 280(17):1484,1998. [PubMed]40.

Look Alike/Sound Mike Drug Names, Ambiguous or Look-Alike Labeling and Packaging. ISMP Quarterly Action Agenda: April–June, 1999, health care organizations ISMP Medication Safety Alert, July 14, 1999. Institute for Safe Medication Practices, Pennsylvania.

Maximize your academic success with just one click! Discover the secret to exceptional grades and elevate your performance to unparalleled heights. Click now to access the ultimate solution to this Question

Explanation & Answer

Our website has a team of professional writers who can help you write any of your homework. They will write your papers from scratch. We also have a team of editors just to make sure all papers are of HIGH QUALITY & PLAGIARISM FREE. To make an Order you only need to click Order Now and we will direct you to our Order Page at Litessays. Then fill Our Order Form with all your assignment instructions. Select your deadline and pay for your paper. You will get it few hours before your set deadline.

Fill in all the assignment paper details that are required in the order form with the standard information being the page count, deadline, academic level and type of paper. It is advisable to have this information at hand so that you can quickly fill in the necessary information needed in the form for the essay writer to be immediately assigned to your writing project. Make payment for the custom essay order to enable us to assign a suitable writer to your order. Payments are made through Paypal on a secured billing page. Finally, sit back and relax.

Do you need an answer to this or any other questions?

Similar Posts